Who
Frances Arnold
Director
Company insider
Files Form 4 as: Director, Alphabet; Director, Generate Biomedicines; Director, Illumina.
In numbers
- Trades disclosed
- 128
- Buys
- 0
- Sells
- 46
- Bought
- $0
- Sold
- $2.9M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 27 Jan 2016
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Sold | $28K83 at $340.45 | filing |
| 14 Sep 2026filed 16 Sep 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —0.4 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —1 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —1 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —11 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —0.4 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —1 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —1 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —11 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GENB Generate BiomedicinesBiotechnology | SEC FORM 4 Sold | $16K1,000 at $16.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | GENB Generate BiomedicinesBiotechnology | SEC FORM 4 Sold | $16K1,000 at $16.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Sold | $28K82 at $337.71 | filing |
| 28 Aug 2026filed 31 Aug 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Sold | $28K82 at $337.71 | filing |
| 30 Jul 2026filed 30 Jul 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Sold | $27K82 at $333.39 | filing |
| 30 Jul 2026filed 30 Jul 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Sold | $27K82 at $333.39 | filing |
| 1 Jul 2026filed 6 Jul 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —980 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —980 at $0.00 | filing |
| 30 Jun 2026filed 30 Jun 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Sold | $39K112 at $351.28 | filing |
| 30 Jun 2026filed 30 Jun 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Sold | $39K112 at $351.28 | filing |
| 15 Jun 2026filed 18 Jun 2026 | GOOGL AlphabetInternet Platforms | SEC FORM 4 Code A | —0.05 at $0.00 | filing |
News
Alphabet: The Q3 Could Change Everything For Investors (NASDAQ:GOOG) (NASDAQ:GOOGL)GOOGL · seekingalpha.com · 22 Oct 2026Alphabet (NASDAQ:GOOGL) Stock Price Target Lowered at Citizens JmpGOOGL · dailypolitical.com · 22 Oct 2026Generate Biomedicines to Participate in November Investor ConferencesGENB · manilatimes.net · 22 Oct 2026Alphabet Inc. (NASDAQ:GOOGL) Stock Has Consensus Price Target of $425.04GOOGL · dailypolitical.com · 20 Oct 2026Zealand And Generate Biomedicines Team Up To Develop AI-Designed Therapies For Metabolic DiseasesGENB · rttnews.com · 14 Oct 2026Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic DiseasesGENB · manilatimes.net · 13 Oct 2026
0 headlines in the last 90 days name Frances Arnold; 6 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.